libri scuola books Fumetti ebook dvd top ten sconti 0 Carrello


Torna Indietro

kanner steven (curatore) - tumor metabolome targeting and drug development
Zoom

Tumor Metabolome Targeting and Drug Development




Disponibilità: Normalmente disponibile in 10 giorni
A causa di problematiche nell'approvvigionamento legate alla Brexit sono possibili ritardi nelle consegne.


PREZZO
162,98 €
NICEPRICE
154,83 €
SCONTO
5%



Questo prodotto usufruisce delle SPEDIZIONI GRATIS
selezionando l'opzione Corriere Veloce in fase di ordine.


Pagabile anche con Carta della cultura giovani e del merito, 18App Bonus Cultura e Carta del Docente


Facebook Twitter Aggiungi commento


Spese Gratis

Dettagli

Genere:Libro
Lingua: Inglese
Editore:

Humana

Pubblicazione: 01/2014
Edizione: 2014





Trama

In this volume, the major metabolic alterations identified in cancer and tumor-associated cells are explored, including discussions of former and emerging approaches to drug development in targeting cancer cell metabolism.

The metabolic network in cells promotes the generation of both energy and biomass needed for them to grow, divide and differentiate. However, the metabolism of malignant cells generally varies from that of normal cells. These differences provide a platform for the discovery of new approaches to targeting potential vulnerabilities in cancer cells for therapeutic options Some of the significant changes that occur involve ATP production and consumption that modulates the ATP to ADP ratio, hypoxia and the effects of reactive oxygen species on glycolysis, regulation of mitochondrial respiration, induction and suppression of autophagy, and the Warburg effect and “reverse” Warburg effect--these topics and more are discussed in this volume.





Sommario

Tumor cell metabolic reprogramming and drug targeting.- Cancer metabolism: a nexus of matter, energy and reactive oxygen species.- Regulating mitochondrial respiration in cancer.- Regulation of cancer cell metabolism by hypoxia.- Glucose metabolism and the anti-oxidative defence system in cancer cells: Options for application of ROS-based anticancer drugs.- Modulating autophagy and the “reverse Warburg effect”.- Metabolic adaptation in reprogrammed cancer cells.- Index.




Autore

Dr. Steven B. Kanner is the Vice President of Discovery Biology at Astex Pharmaceuticals. He has been a pharmaceutical research leader with over 20 years of extensive experience in novel target identification and validation, assay development, both small molecule and antibody drug discovery, and expertise in oncology, immunology and inflammation. For more detail, please see the attached CV herewith.










Altre Informazioni

ISBN:

9781461495444

Condizione: Nuovo
Collana: Cancer Drug Discovery and Development
Dimensioni: 235 x 155 mm
Formato: Copertina rigida
Illustration Notes:VIII, 198 p. 22 illus., 12 illus. in color.
Pagine Arabe: 198
Pagine Romane: viii


Dicono di noi